Azmi Nasser, DO
Physical Medicine & Rehabilitation · Phoenix, AZNPI 1669636478
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,481 of the $45,542 with a category attached, or 62.5%. Joimax, Inc. accounts for 62.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $11,454 and has fallen 75.0% since, to $2,868 in 2025. Among physical medicine & rehabilitation clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $231.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Joimax, Inc.$28K
- Nexxt Spine LLC$7K
- Boston Scientific$4K
- Aurora Spine, Inc.$2K
- Medtronic$2K
- SPR Therapeutics, Inc$1K
- plus $2K from 19 others
What the payments were for
- Consulting fees$28,48163%
- Speaking & faculty fees$2601%
- Travel & lodging$10,54623%
- Food & beverage$6,16914%
- Entertainment$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Joimax, Inc. | 12 | $28,439 |
| Nexxt Spine LLC | 10 | $7,097 |
| Boston Scientific | 60 | $3,537 |
| Aurora Spine, Inc. | 1 | $1,600 |
| Medtronic | 23 | $1,580 |
| SPR Therapeutics, Inc | 25 | $1,105 |
| Abbott | 17 | $562 |
| Pacira Pharmaceuticals Incorporated | 1 | $260 |
| Daiichi Sankyo Inc. | 4 | $228 |
| Relievant Medsystems, Inc. | 3 | $220 |
| Fidia Pharma USA Inc. | 6 | $146 |
| Curonix LLC | 1 | $123 |
| MDD US Operations, LLC | 1 | $110 |
| Sanofi-aventis U.S. LLC | 7 | $100 |
| Scilex Pharmaceuticals Inc. | 5 | $79 |
| Orthogenrx Inc. | 3 | $66 |
| Vertiflex, Inc. | 4 | $58 |
| Biodelivery Sciences International, Inc. | 4 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $44 |
| Foundation Fusion Solutions, LLC | 1 | $38 |
| AstraZeneca(2 entities) | 2 | $37 |
| Valinor Pharma, LLC | 1 | $24 |
| Sentynl Therapeutics, Inc. | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SI System$6,235
- ZIP$1,600
- SYNCHROMEDII$855
- SI Development$717
- NA$500
- SPRINT PNS System$406
- PRECISION$398
- EXPAREL$260
- Intracept$225
- Nexxt Spine Product Offerings$217
- Morphabond ER$166
- PRODIGY$137
- GENERAL PAIN MANAGEMENT$126
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$123
- Lucemyra/Lofexidine$110
How this compares
$45,542 in reported general payments places this provider in the 95th percentile of 162 physical medicine & rehabilitation providers in Arizona.
See all physical medicine & rehabilitation providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $12,431 |
| Xtampza ErOxycodone Myristate | 15 | $7,857 |
| Oxycodone Hcl | 134 | $2,207 |
| Fentanyl | 11 | $1,806 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $1,658 |
| Gabapentin | 73 | $1,119 |
| Lidocaine | 12 | $956 |
| Morphine Sulfate ErMorphine Sulfate | 21 | $673 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $661 |
| Celecoxib | 19 | $550 |
| Pregabalin | 31 | $399 |
| Tramadol Hcl | 41 | $366 |
| Tizanidine Hcl | 11 | $365 |
| Diclofenac Sodium | 11 | $319 |
| Cephalexin | 12 | $116 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $44 | $7,85715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 162 physical medicine & rehabilitation providers in Arizona.
Other physical medicine & rehabilitation in Phoenix
- Christina KwasnicaPhoenix$33K
- Keikhosrow MosallaiePhoenix$11K
- Heather TheobaldPhoenix$9K
- Peter KubitzPhoenix$7K
- Grace MaloneyPhoenix$5K
- Vivek MehtaPhoenix$4K
- Brad SoroskyPhoenix$4K
- Tima lePhoenix$3K
- Julie HastingsPhoenix$3K
- Kevin LadinPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.